Practice Economics

CMS Administrator Tavenner to step down in February


 

References

Centers for Medicare & Medicaid Services Administrator Marilyn Tavenner announced Jan. 16 that she will resign her post at the end of February.

Ms. Tavenner joined CMS in February 2010 and oversaw the implementation of the Affordable Care Act, passed a month into her leadership tenure. She was the first administrator to be confirmed by the U.S. Senate in more than 6 years.

Marilyn Tavenner

Marilyn Tavenner

In a Jan. 16 e-mail to CMS staff, Ms. Tavenner highlighted a number of agency achievements during her time as administrator, commending staff’s “hard work, dedication, commitment, and resolve” that are “truly transforming health care in this country.”

Among the achievements she highlighted were improvements in quality of health care delivered, historically overall low growth in health care spending, increased fraud detection, greater transparency, publication of health care data and indicators, and improved access to health care.

“Marilyn led the effort to accelerate the development and expansion of innovative new health care payment and delivery models,” HHS Secretary Sylvia Burwell said Jan. 16 in an e-mail to all CMS staff.

A low point of Tavenner’s tenure was the troubled launch of HealthCare.gov; however, Ms. Burwell commended her for her work to “help right the ship, bringing aboard a systems integrator and overseeing an overhaul of the website.”

Principal Deputy Administrator Andy Slavitt will take over as acting administrator in March, Ms. Burwell said.

gtwachtman@frontlinemedcom.com

Recommended Reading

Medicare @ 50: Popular with patients; problematic for physicians
MDedge Internal Medicine
Giving patients ownership of data key to solving health IT woes
MDedge Internal Medicine
Gilead’s hepatitis C drugs to be sold exclusively at CVS
MDedge Internal Medicine
Charging doctors with homicide
MDedge Internal Medicine
CMS will hold 2015 Medicare payments for 2 weeks
MDedge Internal Medicine
The EHR ball dropping
MDedge Internal Medicine
Edoxaban approved for atrial fib, DVT, and PE indications
MDedge Internal Medicine
ACP: EHRs need to focus on patient care, not reimbursement
MDedge Internal Medicine
Legislation would ease burden of Stage 2 meaningful use
MDedge Internal Medicine
CDC: Hospital-acquired infections decreasing
MDedge Internal Medicine